Search results
Results From The WOW.Com Content Network
Tuesday, Moderna Inc (NASDAQ:MRNA) stock is trading higher with a session volume of 8.0 million as per data from Benzinga Pro. On Friday, Moderna announced ongoing support from the U.S. Department ...
On Monday, Merck & Co Inc (NYSE:MRK) and Moderna, Inc. (NASDAQ:MRNA) announced the initiation of INTerpath-009, a pivotal Phase 3 trial of V940 (mRNA-4157). V940 is an investigational ...
Unbelievably, it's still not too late to buy Moderna (NASDAQ:MRNA). In fact, the last time I weighed in on MRNA stock, I said the same thing.At the time, the MRNA traded at $48.05 before it ...
Moderna's (NASDAQ: MRNA) struggles may last a little longer than expected. The biotech company had seen both sales and its stock price plummet as demand for its coronavirus vaccine waned, but ...
When Moderna (NASDAQ:MRNA) posted quarterly results on Nov. 4, it lowered its revenue guidance. This sent MRNA stock down from $350 to below $250. More recently, the emergence of omicron, another ...
mRNA specialist Moderna (MRNA) is among the leading players in the race to be first to market with a COVID-19 vaccine and the market has been kind in return. Overall, the stock is up 254% year-to ...
Monday, Moderna, Inc.’s (NASDAQ:MRNA) manufacturing facility in Laval, Quebec, received a Drug Establishment License (DEL) from Health Canada. ... Price Action: MRNA stock is up 6.70% at $77.77 ...
Moderna (MRNA) stock has been one of 2020’s star performers, up 695%, and judging by its real-world results, many would say justifiably so.The biggest question for investors, then, is whether ...